EMED (Electromedical Technologies) Total Liabilities: $4.57 Mil (As of Sep. 2024)


What is Electromedical Technologies Total Liabilities?

Electromedical Technologies EMED Total Liabilities is $4.57 Mil as of Sep. 2024.

Electromedical Technologies's Total Liabilities for the quarter that ended in Sep. 2024 was $4.57 Mil.

Electromedical Technologies's quarterly Total Liabilities declined from Mar. 2024 ($4.40 Mil) to Jun. 2024 ($4.07 Mil) but then increased from Jun. 2024 ($4.07 Mil) to Sep. 2024 ($4.57 Mil).

Electromedical Technologies's annual Total Liabilities increased from Dec. 2021 ($2.13 Mil) to Dec. 2022 ($3.57 Mil) and increased from Dec. 2022 ($3.57 Mil) to Dec. 2023 ($3.62 Mil).

Electromedical Technologies Total Liabilities Historical Data

* Premium members only.

The historical data trend for Electromedical Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromedical Technologies Total Liabilities Chart

Electromedical Technologies Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
3.09 2.74 2.13 3.57 3.62

Electromedical Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.37 3.62 4.40 4.07 4.57

Electromedical Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Electromedical Technologies's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.357+(0.256+0.0079999999999998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=3.62

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=0.748--2.873
=3.62

Electromedical Technologies's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=4.356+(0.214+0.004
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=4.57

Total Liabilities=Total Assets (Q: Sep. 2024 )-Total Equity (Q: Sep. 2024 )
=0.569--4.005
=4.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $4.57 Mil mean?
Electromedical Technologies (EMED) has a Total Liabilities of $4.57 Mil as of Sep. 2024. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Electromedical Technologies and its competitors.
Is Electromedical Technologies' Total Liabilities too high?
Electromedical Technologies' current Total Liabilities is $4.57 Mil.
How does Electromedical Technologies' Total Liabilities compare to DYNT and SONX?
Electromedical Technologies' Total Liabilities of $4.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Electromedical Technologies and its competitors. Electromedical Technologies's current Total Liabilities is $4.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromedical Technologies stock overvalued right now?
Electromedical Technologies (EMED) has a current Total Liabilities of $4.57 Mil. The current Total Liabilities is $4.57 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Electromedical Technologies (EMED), the current Total Liabilities is $4.57 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Electromedical Technologies Business Description

Address 10105 E. Via Linda, No. 103-300, Scottsdale, AZ, USA, 85258
Electromedical Technologies Inc is a Delaware-based bioelectronics manufacturing company. The company designs, develops, and markets FDA-cleared, non-invasive, and simple-to-use bioelectronics therapy medical devices that serve as drug-free alternatives for pain relief. The company's device provide immediate and long-lasting pain relief across the broadest range of ailments. It focuses on improving globalised wellness for people suffering from various painful conditions.